Amyloid-beta glycation induces neuronal mitochondrial dysfunction and Alzheimer’s pathogenesis via VDAC1-dependent mtDNA efflux
Proceedings of the National Academy of Sciences · 25.11.2025 · 122 (47)
DOI: 10.1073/pnas.2505046122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 17.11.2025. Verfasst von Firoz Akhter und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794. Hauptthemen laut MEDLINE: Voltage-Dependent Anion Channel 1, Alzheimer Disease, Mitochondria, Neurons. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Glycation, the nonenzymatic attachment of reactive dicarbonyls to proteins, lipids, or nucleic acids, contributes to the formation of advanced glycation end-products (AGEs). In Alzheimer’s disease (AD), amyloid-beta (Aβ) undergoes posttranslational glycation to produce glycated Aβ (gAβ), yet its pathological role remains poorly understood. Here, we demonstrate that gAβ promotes neuronal mitochondrial DNA (mtDNA) efflux via a VDAC1-dependent mechanism, activating the innate immune cGAS-STING pathway. Using aged AD mice and human AD brain samples, we observed cGAS-mtDNA binding and cGAS-STING activation in the neuronal cytoplasm. Knockdown of RAGE, cGAS, or STING, as well as pharmacological inhibition of VDAC1, protected APP mice from mitochondrial dysfunction and Alzheimer’s-like pathology. Neuron-specific cGAS knockdown confirmed its pivotal role in driving neuroinflammation and cognitive deficits. Treatment with ALT-711, an AGE cross-link breaker, alleviated gAβ-associated pathology. Furthermore, RAGE inhibition in APP knock-in mice suppressed innate immune activation and disease-associated gene expression, as revealed by spatially resolved transcriptomics. Collectively, our findings establish a mechanistic link between gAβ and innate immune activation, identifying VDAC1, the AGE-RAGE axis, and the cGAS-STING pathway as promising therapeutic targets in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794.
- Department of Pathology, Case Western Reserve University, Cleveland, OH 44106.
- Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, NY 11794.
- Department of Neurobiology and Behavior, Neuroscience Graduate Program, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794.
- Department of Chemistry, Nuclear Magnetic Resonance Core Laboratory, University of Kansas, Lawrence, KS 66045.
- Alfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, CA 90033.
ORCID-Profile: Firoz Akhter, Xiongwei Zhu, Justin T Douglas, Zhen Zhao, Donghui Zhu
Förderung
- NIA NIH HHS
Zitieren
APA
Akhter, F., Akhter, A., Zhu, X., Schiff, H., Maffei, A., Douglas, J. T., Zhou, Q., Zhao, Z., & Zhu, D. (2025). Amyloid-beta glycation induces neuronal mitochondrial dysfunction and Alzheimer’s pathogenesis via VDAC1-dependent mtDNA efflux. Proceedings of the National Academy of Sciences, 122(47). https://doi.org/10.1073/pnas.2505046122
Vancouver
Akhter F, Akhter A, Zhu X, Schiff H, Maffei A, Douglas JT, et al. Amyloid-beta glycation induces neuronal mitochondrial dysfunction and Alzheimer’s pathogenesis via VDAC1-dependent mtDNA efflux. Proceedings of the National Academy of Sciences. 2025;122(47). doi:10.1073/pnas.2505046122
BibTeX
@article{Akhter2025,
author = {Akhter, Firoz and Akhter, Asma and Zhu, Xiongwei and Schiff, Hillary and Maffei, Arianna and Douglas, Justin T and Zhou, Qifa and Zhao, Zhen and Zhu, Donghui},
title = {Amyloid-beta glycation induces neuronal mitochondrial dysfunction and Alzheimer’s pathogenesis via VDAC1-dependent mtDNA efflux},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {47},
doi = {10.1073/pnas.2505046122}
}
EUVIMED